SMTL ID : 3ggx.3 (3 other biounits)

HIV Protease, pseudo-symmetric inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

homo-dimer

Ligands

1 x GGX: methyl [(1S)-1-{[(1R,3S,4S)-4-{[(2S)-3,3-dimethyl-2-{3-[(6-methylpyridin-2-yl)methyl]-2-oxo-2,3-dihydro-1H-imidazol-1-yl}butanoyl]amino}-3-hydroxy-5-phenyl-1-(4-pyridin-2-ylbenzyl)pentyl]carbamoyl}-2,2-dimethylpropyl]carbamate(Non-covalent)

GGX.1: 24 residues within 4Å: Chain A: R.8, L.23, D.25, G.27, A.28, D.29, G.48, G.49, I.50, P.81, V.82, I.84 Chain B: R.8, L.23, D.25, G.27, A.28, D.29, G.48, G.49, I.50, P.81, V.82, I.84 19 PLIP interactions: 13 interactions with chain A, 6 interactions with chain B Hydrophobic interactions: A:L.23, A:A.28, A:I.50, A:P.81, A:V.82, A:I.84, B:L.23, B:I.50, B:I.50, B:I.84 Hydrogen bonds: A:R.8, A:D.25, A:G.27, A:D.29, A:G.48, A:I.50, B:G.27, B:D.29 pi-Cation interactions: A:R.8

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Degoey, D.A. et al., 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. J.Med.Chem. (2009)

Release Date

2009-05-26

Peptides

V-1 protease: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
E

B
F

V-1 protease

Related Entries With Identical Sequence